Daily Stock Analysis, ABT, Abbott Laboratories, priceseries

Abbott Laboratories. Daily Stock Analysis
Stock Information
Open
61.22
Close
61.84
High
61.97
Low
61.22
Previous Close
61.39
Daily Price Gain
0.45
YTD High
64.29
YTD High Date
Jan 25, 2018
YTD Low
55.32
YTD Low Date
Feb 9, 2018
YTD Price Change
3.61
YTD Gain
6.20%
52 Week High
64.29
52 Week High Date
Jan 25, 2018
52 Week Low
42.55
52 Week Low Date
May 24, 2017
52 Week Price Change
19.16
52 Week Gain
44.89%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 10. 2017
41.65
Mar 6. 2017
43.99
15 Trading Days
5.63%
Link
LONG
May 26. 2017
43.83
Jun 28. 2017
47.59
22 Trading Days
8.57%
Link
LONG
Dec 18. 2017
55.87
Feb 2. 2018
61.49
31 Trading Days
10.06%
Link
Company Information
Stock Symbol
ABT
Exchange
NYSE
Company URL
http://www.abbott.com
Company Phone
8479376100
CEO
Miles D. White
Headquarters
Business Address
100 ABBOTT PARK ROAD, D-322 AP6D, ABBOTT PARK, IL 60064-3500
Sector
Equity
Industry Category
Industry Group
CIK
About

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Description

Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.